). In contrast, the plasmacytoma lines H929 (Gazdar et al., 1986 ) and U266B1 (Nilsson et al., 1970 ) and the myeloma cell line P3U1 (Unkeless, 1979 ) exhibited little to no expression of these two proteins, suggesting that these cell lines could be utilized to investigate physical and functional interactions between the repressor BCL-6 and the corepressor Mi-2/NuRD.
MTA3 Associates with BCL-6
Exogenous expression of BCL-6 and MTA3 with epitope To dissect the interaction between MTA3 and BCL-6, protein-protein interaction assays were employed. Sevfashion. Together, these data suggest a prominent role for MTA3 in B cell fate determination.
eral regions of BCL-6 were produced in recombinant bacteria as GST fusions. The purified GST-BCL-6 derivatives were subsequently incubated with nuclear extracts Results from Raji cells. In this assay, robust interaction of BCL-6 with MTA3 and the Mi-2/NuRD complex was observed
MTA3 Expression in Lymphoid Tissue
In an immunohistochemical survey of MTA3 expression using the central region of the BCL-6 protein ( Figure  3A ). Other regions of BCL-6, including the BTB-POZ in breast cancer specimens (Fujita et al., 2003) , a slide containing a lymph node was encountered. Closer exdomain, failed to interact productively with MTA3 and the Mi-2/NuRD complex. This result was somewhat suramination of this and other slides containing secondary lymphoid tissues revealed high-level expression of prising as the interaction between BCL-6 and other corepressors, including NCoR (Huynh and Bardwell, 1998), MTA3 at germinal centers. 
The MTA3 Mi-2/NuRD Complex Directs Repression by the BCL-6 Central Repression Domain
The coordinate expression and physical interaction of BCL-6 with MTA3 suggested a functional interaction. To investigate the potential role of MTA3 in transcriptional repression by BCL-6, we employed a Gal4 tethering assay. BCL-6 fused in-frame to the Gal4 DNA binding domain was cotransfected into HeLa cells with a constitutively expressing luciferase reporter construct containing Gal4 binding sites (Fujita et al., 2003) . HeLa cells were utilized because they are readily transfected and they express endogenous MTA3 at high levels (Fujita et al., 2003) . Gal4-BCL-6 repressed transcription from the reporter in a dose-dependent manner ( Figure 3C) Wong and Privalsky, 1998), specific regions of BCL-6 were tested in this assay for repressive activity. As expected, the BTB-POZ domain when fused to the Gal4 DNA binding domain repressed transcription from the reporter in a dose-dependent manner. However, a mutant version of BCL-6 lacking the BTB-POZ domain (construct ⌬2, Figure 3C ) also functioned as a transcriptional repressor in this assay. Further deletion mutations mapped the minimal region sufficient for transcriptional repression to the central 367 amino acids (construct ⌬5, Figure 3C ). These data suggested that BCL-6 has two independent transcriptional repression domains: the BTB-POZ domain and the central region.
To investigate the requirement for MTA3 function in transcriptional repression driven by BCL-6 in the Gal4 tethering assay, RNA interference was utilized. In the Gal4 tethering assay, transcriptional repression by fulllength BCL-6 was reduced by MTA3 siRNA treatment ( Figure 3D ). Repression driven by the central region of BCL-6 was affected to a somewhat greater extent by MTA3 depletion. We concluded that MTA3 contributes with the acetylation sites of BCL-6 ( Figure 3A) , we asked whether BCL-6 acetylation status impacted MTA3-dependent transcriptional repression. Mutant versions a direct interaction between BCL-6 and MTA3, proteinprotein interaction assays were performed with recomof BCL-6 were constructed that either prevent any acetylation (KKYK to KKYR mutation) or mimic constitutive binant fragments of each protein. GST-MTA3 fusions were prepared in recombinant bacteria, purified, and acetylation (KKYK to QQYQ) in the context of the Gal4-BCL-6 fusion. Transcriptional repression assays were tested for interaction with a purified recombinant fragment of BCL-6 containing the central region ( Figure 3B ). again performed in HeLa cells using the luciferase reporter described above ( Figure 3E ). Both wild-type The carboxy-terminal 137 amino acids of MTA3 interacted specifically with the BCL-6 fragment in this assay, BCL-6 and the KKYR mutant exhibited robust transcrip- tional repression activity in the tethering assay. In coneffect that was modestly enhanced by Trichostatin-A. Importantly, the amount of BCL-6 coprecipitating with trast, the QQYQ mutant, which mimics constitutive acetylation, was unable to direct transcriptional repression MTA3 was reduced by deacetylase inhibition (Figure 3G ). of the reporter.
The above results suggest that the MTA3-dependent As MTA3 is physically associated with HDAC1 and HDAC2 in the context of the Mi-2/NuRD complex (Fujita repression function of BCL-6 is sensitive to the acetylation status of BCL-6. As MTA3 interacts directly with et al., 2003) , we asked whether depletion of endogenous MTA3 from B lymphocyte cell lines might alter the BCL-6, in a region including the sites of acetylation, we asked whether modification status of BCL-6 affected its steady-state levels of acetylated BCL-6. We were unable to achieve sufficient transfection of lymphocytes with capacity to interact with MTA3. For these experiments, BCL-6 derivatives were expressed exogenously in HeLa siRNA, therefore we resorted to an alternative strategy. An adenovirus was constructed to deliver a DNA concells that express high levels of NCoR, SMRT, and MTA3 ( Figure 2D ). Immunoprecipitation of BCL-6 was followed struct encoding a short hairpin RNA ( anti-MTA3 antibody was performed as described previously (Fujita et al., 2003) . Antigen unmasking and staining of cell pellets with antibodies to CD20, CD138, and kappa and lambda immunoglobulin RNA Extraction and RT-PCR light chains (DAKO) were performed according to manufacturer's Total RNA was extracted by a modified guanidium thiocyanateinstructions. Detection with the LSAB2 System (DAKO) for immunophenol-chloroform extraction as described (Fujita et al., 2003) . cDNA peroxidase staining followed the manufacturer's recommendations. was synthesized with M-MLV reverse transcriptase (Life TechnoloFollowing diaminobenzidine (DAB) exposure, sections were coungies) using random hexamers as described (Fujita et al., 2003) . The terstained with hematoxylin before mounting for light microscopy cDNA was amplified using the following primers: and photography. Blimp1: 5Ј-ACTTGCAACAAGGGCTTTAc-3Ј; 5Ј-ACCTTGCATTGG TATGGTTT-3Ј
